Tenet Healthcare Statistics
Total Valuation
THC has a market cap or net worth of $14.07 billion. The enterprise value is $27.46 billion.
| Market Cap | 14.07B |
| Enterprise Value | 27.46B |
Important Dates
The last earnings date was Tuesday, October 29, 2024, before market open.
| Earnings Date | Oct 29, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
THC has 95.10 million shares outstanding. The number of shares has decreased by -4.90% in one year.
| Current Share Class | 95.10M |
| Shares Outstanding | 95.10M |
| Shares Change (YoY) | -4.90% |
| Shares Change (QoQ) | -1.82% |
| Owned by Insiders (%) | 1.04% |
| Owned by Institutions (%) | 95.23% |
| Float | 94.00M |
Valuation Ratios
The trailing PE ratio is 4.73 and the forward PE ratio is 13.02. THC's PEG ratio is 0.58.
| PE Ratio | 4.73 |
| Forward PE | 13.02 |
| PS Ratio | 0.71 |
| Forward PS | 0.66 |
| PB Ratio | 3.77 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 5.87 |
| P/OCF Ratio | 4.38 |
| PEG Ratio | 0.58 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 6.82, with an EV/FCF ratio of 11.47.
| EV / Earnings | 8.78 |
| EV / Sales | 1.31 |
| EV / EBITDA | 6.82 |
| EV / EBIT | 8.62 |
| EV / FCF | 11.47 |
Financial Position
The company has a current ratio of 1.58, with a Debt / Equity ratio of 1.59.
| Current Ratio | 1.58 |
| Quick Ratio | 1.38 |
| Debt / Equity | 1.59 |
| Debt / EBITDA | 2.89 |
| Debt / FCF | 5.38 |
| Interest Coverage | 3.75 |
Financial Efficiency
Return on equity (ROE) is 59.57% and return on invested capital (ROIC) is 9.68%.
| Return on Equity (ROE) | 59.57% |
| Return on Assets (ROA) | 6.99% |
| Return on Capital (ROIC) | 9.68% |
| Revenue Per Employee | $196,920 |
| Profits Per Employee | $29,352 |
| Employee Count | 106,500 |
| Asset Turnover | 0.74 |
| Inventory Turnover | 32.97 |
Taxes
In the past 12 months, THC has paid $1.16 billion in taxes.
| Income Tax | 1.16B |
| Effective Tax Rate | 22.77% |
Stock Price Statistics
The stock price has increased by +127.74% in the last 52 weeks. The beta is 2.15, so THC's price volatility has been higher than the market average.
| Beta (5Y) | 2.15 |
| 52-Week Price Change | +127.74% |
| 50-Day Moving Average | 159.24 |
| 200-Day Moving Average | 133.04 |
| Relative Strength Index (RSI) | 39.38 |
| Average Volume (20 Days) | 1,564,345 |
Short Selling Information
The latest short interest is 2.41 million, so 2.53% of the outstanding shares have been sold short.
| Short Interest | 2.41M |
| Short Previous Month | 2.97M |
| Short % of Shares Out | 2.53% |
| Short % of Float | 2.56% |
| Short Ratio (days to cover) | 1.92 |
Income Statement
In the last 12 months, THC had revenue of $20.97 billion and earned $3.13 billion in profits. Earnings per share was $31.26.
| Revenue | 20.97B |
| Gross Profit | 8.29B |
| Operating Income | 3.19B |
| Pretax Income | 3.76B |
| Net Income | 3.13B |
| EBITDA | 4.03B |
| EBIT | 3.19B |
| Earnings Per Share (EPS) | $31.26 |
Balance Sheet
The company has $4.09 billion in cash and $12.87 billion in debt, giving a net cash position of -$8.78 billion or -$92.30 per share.
| Cash & Cash Equivalents | 4.09B |
| Total Debt | 12.87B |
| Net Cash | -8.78B |
| Net Cash Per Share | -$92.30 |
| Equity (Book Value) | 8.08B |
| Book Value Per Share | 40.32 |
| Working Capital | 3.22B |
Cash Flow
In the last 12 months, operating cash flow was $3.20 billion and capital expenditures -$809.00 million, giving a free cash flow of $2.39 billion.
| Operating Cash Flow | 3.20B |
| Capital Expenditures | -809.00M |
| Free Cash Flow | 2.39B |
| FCF Per Share | $25.16 |
Margins
Gross margin is 39.55%, with operating and profit margins of 15.20% and 14.91%.
| Gross Margin | 39.55% |
| Operating Margin | 15.20% |
| Pretax Margin | 24.38% |
| Profit Margin | 14.91% |
| EBITDA Margin | 19.21% |
| EBIT Margin | 15.20% |
| FCF Margin | 28.64% |
Dividends & Yields
THC does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 4.90% |
| Shareholder Yield | 4.90% |
| Earnings Yield | 22.27% |
| FCF Yield | 17.05% |
Analyst Forecast
The average price target for THC is $160.67, which is 8.62% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $160.67 |
| Price Target Difference | 8.62% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 18 |
| Revenue Growth Forecast (5Y) | 3.57% |
| EPS Growth Forecast (5Y) | 16.99% |
Stock Splits
The last stock split was on October 11, 2012. It was a reverse split with a ratio of 0.25:1.
| Last Split Date | Oct 11, 2012 |
| Split Type | Reverse |
| Split Ratio | 0.25:1 |
Scores
THC has an Altman Z-Score of 1.63 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.63 |
| Piotroski F-Score | 7 |